The Trump administration will not give Utah or other states federal funding to partially expand their Medicaid programs under the Affordable Care Act; if a Medicare for all system operates the same way as traditional Medicare, the program would be “wastefully expensive,” authors warn; the creator of the widely used screening test to screen for early signs of cognitive decline is insisting on training for those who administer it.
The Trump administration will not give Utah or other states federal funding to partially expand their Medicaid programs under the Affordable Care Act, The Washington Post reported. CMS authorized the state to move forward on a so-called “partial expansion” earlier this year to a limited number of people. Utah had hoped to receive additional US funding even though it was not fully expanding Medicaid. According to the report, the White House claimed that it did not make sense to approve the more generous funding while arguing in court at the same time that the entire ACA should be overturned.
What would a Medicare for all system cover? Most people are focused on taxes and access, but in a New York Times column, Austin Frakt, PhD, and Elsa Pearson, MPH, noted that unlike in other countries, which often refuse to pay for therapies where the cost exceeds the benefits, traditional Medicare rarely denies claims. In a 2018 report to Congress, the Medicare Payment Advisory Commission noted that up to one-third of beneficiaries received some kind of low-value treatment in 2014, costing the program billions of dollars. If Medicare for all operated the same way, the program would be “wastefully expensive,” they wrote.
The creator of the widely used screening test to screen for early signs of cognitive decline is insisting on training for those who administer it, Kaiser Health News reported. Starting September 1, most clinicians who administer the Montreal Cognitive Assessment (MoCA) will be required to complete a 1-hour, $125 online course. Ziad Nasreddine, MD, said increasing concerns about the validity of test results, as well as possible liability for errors, spurred the changes. The test was used last year by President Donald Trump’s then-physician, who said the president scored a 30 out of 30.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More